| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 03/31/2010 | CN101683332A high purity scutellarin salt bulk drug and preparation method thereof |
| 03/30/2010 | US7687503 2-(methylamino)-2-oxoethyl 4-{5-[3-(trifluoromethyl)-phenyl]-2-pyridyl}-1-piperazinecarboxylate, for example; enzyme inhibitors of fatty acid amide hydrolases; treatment of pain, eating disorders, neurological and psychiatric pathologies, among other disorders |
| 03/30/2010 | US7687282 Detection of transmembrane potentials by optical methods |
| 03/30/2010 | CA2412232C Process for the preparation of nitroalkenes |
| 03/30/2010 | CA2385725C Novel indeno-fused photochromic naphthopyrans |
| 03/25/2010 | WO2010033011A1 Rosamine derivatives as agents for the treatment of cancer |
| 03/25/2010 | WO2010032771A1 Amino acid derivative |
| 03/25/2010 | US20100076206 Process for preparing nebivolol |
| 03/25/2010 | US20100076066 Novel IDO Inhibitors and Methods of Use Thereof |
| 03/25/2010 | US20100075953 Substituted piperazines, (1,4) diazepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 03/25/2010 | US20100075926 Activation of histone deacetylase 1 (hdac1) protects against dna damage and increases neuronal survival |
| 03/25/2010 | CA2737431A1 Amino acid derivative |
| 03/24/2010 | CN101679849A Fluorescent cell markers |
| 03/24/2010 | CN101679341A 3',4',5-trimethoxy flavone derivatives as stimulant of mucus secretion, method of the same, and pharmaceutical composition comprising the same |
| 03/23/2010 | US7683202 Permanent surface modifiers |
| 03/23/2010 | US7683189 2,2-dimethyl 2H-1-benzopyran compound having a nitro group on the benzene ring thereof is reacted with hydrazine in the presence of a metal catalyst and the corresponding aminobenzopyran compound is produced; intermediates for synthesizing e.g., antifibrillatory agents |
| 03/23/2010 | US7683095 Compositions and methods of treating, reducing and preventing cardiovascular diseases and disorders with polymethoxyflavones |
| 03/23/2010 | US7682637 Efficient method for producing compositions enriched in total phenols |
| 03/23/2010 | CA2356680C Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process |
| 03/23/2010 | CA2196656C Method for the preparation of (±)-calanolide a and intermediates thereof |
| 03/18/2010 | WO2010030781A2 Aromatic carboxylic acid derivatives for treatment and prophylaxis of gastrointestinal diseases including colon cancer |
| 03/18/2010 | US20100069653 Method for enantioselective hydrogenation of chromenes |
| 03/18/2010 | US20100069652 The Process for Preparing Nebivolol |
| 03/18/2010 | US20100069651 Process for production of delta-9-tetrahydrocannabinol |
| 03/18/2010 | US20100069480 Methods and compositions for the treatment of cancer |
| 03/18/2010 | US20100069478 Isoflavone derivatives and uses thereof |
| 03/18/2010 | US20100069477 Methioninase inhibitor and composition and food or drink containing the same |
| 03/18/2010 | US20100069474 Novel coumarin derivatives as ion channel openers |
| 03/18/2010 | US20100069379 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 03/18/2010 | US20100068748 Fluorescent Ion Indicators for Cadmium and Lanthanide Ion Detection |
| 03/17/2010 | EP2163551A1 An improved process for the preparation of nebivolol hydrochloride |
| 03/17/2010 | EP1834195B1 Photochromic intraocular lens |
| 03/17/2010 | CN101671357A (S)-Alpha, Alpha-fluorine-containing diaryl-2-pyrrolidine methanol derivative as well as preparation and applications thereof |
| 03/17/2010 | CN101671336A Aromatic heterocyclic pyridine derivatives and analogs and preparation method and application thereof |
| 03/17/2010 | CN101671325A Pronephrium megacuspe compound, preparation method thereof and application |
| 03/16/2010 | US7678831 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis |
| 03/11/2010 | WO2010026743A1 Reagent for measuring hypoxic environment |
| 03/11/2010 | US20100063305 Method of producing s-(-)-6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid and product obtained by the method |
| 03/11/2010 | US20100063140 Water-soluble compositions of bioactive lipophilic compounds |
| 03/11/2010 | US20100063129 4-Diallylaminomethylene-6-hydroxy-1- alpha -methoxymethyl-10 beta ,13 beta -dimethyl-3,7,17-trioxo-1,3,4,7,10,11 beta ,12,13,14 alpha ,15,16,17-dodecahydro-2-oxa-cyclopenta[ alpha ] phenanthren-11-ol or its acetate in a carrier; PI-3 kinase inhibitor; treating color cancer |
| 03/11/2010 | US20100062131 Flavan-3-ol containing foodstuffs |
| 03/11/2010 | US20100062078 Pharmaceutical composition for treating cancer and the signaling pathway thereof |
| 03/11/2010 | US20100062065 Pharmaceutical composition containing naphthoquinone-based compound for intestine delivery system |
| 03/11/2010 | US20100059711 Fused naphthalenes |
| 03/10/2010 | EP2161262A1 THCV and THCV extracts derived from plant material |
| 03/10/2010 | EP2161261A1 Materials and methods for treating coagulation disorders |
| 03/10/2010 | EP2160385A1 2-substituted isoflavonoid compounds, medicaments and uses |
| 03/10/2010 | EP1651628B1 Antibiotic compound |
| 03/10/2010 | EP1445257B1 2h-1-benzopyran compounds for use in a photochromic material |
| 03/10/2010 | EP0980363B1 Preparation of isoflavones from legumes |
| 03/10/2010 | CN101665482A Method for purifying proanthocyanidins in peanut coat |
| 03/10/2010 | CN101665481A Eriosema chinense isoflavoid compound and extraction method and application thereof |
| 03/10/2010 | CN101665480A Eriosema chinense isoflavoid extract and extraction method and application thereof |
| 03/10/2010 | CN101665479A Technology for synchronously extracting isofraxidin and flavonoids compounds from sarcandra glabra and applications thereof |
| 03/09/2010 | US7674922 Process for production of delta-9-tetrahydrocannabinol |
| 03/09/2010 | US7674918 xanthene-derived fluorophore which may be covalently attached to a target molecule to form a complex, for use in cell analysis techniques, particularly pH measurement and analysis of kinetics of migration |
| 03/09/2010 | US7674823 DNA-PK inhibitors |
| 03/09/2010 | US7674398 substituted cumarines that are capable of emitting fluorescent light when illuminated by wave lengths within ultraviolet range; can be used in objects of great value for its owner, in view of facilitating the identification of such objects |
| 03/09/2010 | CA2336702C Sulfonylaminocarboxylic acid n-arylamides as guanylate cyclase activators |
| 03/04/2010 | WO2010024396A1 NOVEL EPIGALLOCATECHIN GALLATE TRIMER, AND α-GLUCOSIDASE INHIBITOR COMPRISING EPIGALLOCATECHIN GALLATE POLYMER |
| 03/04/2010 | WO2010024393A1 Novel epigallocatechin gallate tetramer, and vascular endothelial function improver comprising same |
| 03/04/2010 | WO2010024138A1 Glucosyltransferase inhibitor comprising epigallocatechin gallate polymer as active ingredient |
| 03/04/2010 | WO2010023512A1 Novel vanilloid receptor modulators, process for their preparation and pharmaceutical compositions containing them |
| 03/04/2010 | WO2010023448A1 Novel potassium channel blockers |
| 03/04/2010 | WO2010023445A1 Novel potassium channel blocker |
| 03/04/2010 | WO2010022520A1 Improved synthesis of hexahydrodibenzopyranones |
| 03/04/2010 | WO2009152210A3 Coumarin compounds and their use for treating cancer |
| 03/04/2010 | US20100056813 Process for preparing nebivolol |
| 03/04/2010 | US20100056812 Composition for treating cancer cells and preparation method for the same |
| 03/04/2010 | US20100056811 Synthesis of Hexahydrodibenzopyranones |
| 03/04/2010 | US20100056810 2h-chromenes annelated at c5-c6 and methods of making and using thereof |
| 03/04/2010 | US20100056808 Prostaglandin synthesis and intermediates for use therein |
| 03/04/2010 | US20100056807 Prostaglandin synthesis and intermediates for use therein |
| 03/04/2010 | US20100051826 Fluorescent Xanthenes and White Light Fluorophores |
| 03/03/2010 | EP2159223A2 6 -acyloxy- 7-meth0xy- 2, 2 -dimethylchromane compounds and their use as pigmentation-regulators |
| 03/03/2010 | EP1945625B1 Photochromic spirodihydrophenanthropyrans |
| 03/03/2010 | CN101659649A Novel epigallocatechin gallate tetramer, and vascular endothelial function improver comprising same |
| 03/03/2010 | CN101659648A Daidzein derivative and preparation method thereof |
| 03/02/2010 | US7671220 Preparation of 6-fluoro-3,3-dimethyl-2,3-dihydro-4H-chromen-4-one by reacting6-fluoro-2,3pdihydro-4H-chromen-4-one with methyl iodide in a tetrahydrofuransolvent with potassium tert-butoxide at low temperatures; new chemicalintermediates for antidepressants |
| 03/02/2010 | US7671218 Phosphonate derivatives of xanthene-based dyes, typically fluorescein, rhodamine or rhodol derivatives; provides additional hydrophilicity to the dye molecules which increases their solubility in aqueous solutions; compatible conditions used on commercialoligonucleotide biosynthsizers |
| 03/02/2010 | US7671201 Phenyl substituted cyclic derivatives |
| 03/02/2010 | US7671085 Non-steroidal farnesoid X receptor modulators and methods for the use thereof |
| 03/02/2010 | US7671084 Dibenzo chromene derivatives and their use as ERβ selective ligands |
| 03/02/2010 | CA2445207C Process for the preparation of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chroman |
| 02/28/2010 | CA2676759A1 Prostaglandin synthesis and intermediates for use therein |
| 02/28/2010 | CA2639240A1 Prostaglandin synthesis and intermediates for use therein |
| 02/25/2010 | WO2010020770A1 Polydialkylsiloxane-bridged bi-photochromic molecules |
| 02/25/2010 | WO2009121710A3 Process for preparing nebivolol |
| 02/25/2010 | US20100048921 Pharmaceutically active compounds |
| 02/25/2010 | US20100048920 Preparation of (+)-Catechin, (-)-Epicatechin, (-)-Catechin, and (+)-Epicatechin and Their 5,7,3',4'-Tetra-O-Benzyl Analogues |
| 02/25/2010 | US20100048887 Compounds including an anti-inflammatory pharmacore and methods of use |
| 02/25/2010 | US20100048882 N-(7-((3aR,4R,7R,7aR)-7-methoxy-6,6-dimethyl-2-oxo-tetrahydro-3aH- [1,3]dioxolo[4,5-c]pyran-4-yloxy)-2-oxo-2H-chromen-3-yl)acetamide; heat shock protein 90 inhibitors; gene expression inhibition; anticarcinogenic agents; neuroprotective agents |
| 02/25/2010 | US20100048688 Dietary and pharmaceutical compositions containing carnosol and/or rosmanol and their uses |
| 02/25/2010 | US20100048604 Ligands for Aldoketoreductases |
| 02/25/2010 | US20100048590 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 02/25/2010 | US20100048512 Radiation protection drug containing tocopherol or tocotrienol compound ester derivative as active ingredient |
| 02/25/2010 | US20100047859 Silica-based fluorescent nanoparticles |
| 02/24/2010 | EP2157086A1 Method for producing glycoside aglycone |
| 02/24/2010 | EP2155888A1 Process for producing compositions comprising tocoherols and tocotrienols |
| 02/24/2010 | EP1000999B1 Compounds for organic el devices and organic el devices |